Understanding GLP-1 Medications in Diabetes Care

For years, the path for treating type 2 diabetes followed a familiar pattern: start with lifestyle changes, add oral medications, and eventually transition to insulin if needed. But today, that pathway looks very different.

A newer class of injectable medications, commonly known as GLP-1 receptor agonists, is changing how we approach diabetes care.

What does “GLP‑1” mean?

GLP‑1 stands for glucagon‑like peptide‑1. It is a hormone released from the gut after eating. GLP‑1 helps:

• Tell your brain you are full

• Reduce hunger

• Slow digestion so you stay full longer

• Improve blood sugar levels

GLP‑1 medications are designed to act like this hormone, but last much longer in the body.

Common GLP‑1 medications (generic names)

You may hear these medicines called by brand names, but doctors prescribe them by their generic names, which include:

• Semaglutide (Ozempic®, Wegovy®)

• Tirzepatide (Mounjaro®, Zepbound®)

• Liraglutide (Victoza®, Saxenda®)

• Dulaglutide (Trulicity®)

• Exenatide (Byetta®, Bydureon®)

Even though the brand names differ, these medicines work in similar ways.

A Shift in Diabetes Treatment

Not long ago, moving from a pill to an injection meant one thing: insulin. Now, that’s no longer the case.

GLP-1 medications have become increasingly popular over the past several years, offering another option before insulin is even considered. These medications help lower blood sugar, but they also do something that has captured widespread attention: They support weight loss.

That combination has made them a frequent topic of conversation in the exam room. In fact, many providers now field questions about these medications almost daily.

Why Are GLP-1 Medications So Popular?

While GLP-1 medications are highly effective for managing diabetes, much of their recent popularity has been driven by their impact on weight.

As demand has grown, so have challenges with access. Some pharmacies have struggled to keep these medications in stock, and patients have sought alternatives, such as compounding pharmacies or med spas, to obtain them.

However, these alternatives come with important considerations. Compounded versions may differ slightly from FDA-approved medications, and recent regulatory updates are working to ensure safer and more standardized formulations.

Cost and Coverage Challenges

Insurance coverage can vary widely, especially when these medications are prescribed for weight loss rather than diabetes.

For patients with diabetes, coverage is often more straightforward, particularly when certain criteria are met, such as an elevated A1C or the presence of other health conditions like high blood pressure, high cholesterol, sleep apnea, or chronic kidney disease.

Even with coverage, cost can still be a barrier. Without it, monthly expenses can be significant, leading some patients to seek lower-cost alternatives.

What About Side Effects?

Like any medication, GLP-1 therapies come with potential side effects. The most common include:

• Nausea

• Constipation or diarrhea

• Occasional vomiting

These symptoms often occur shortly after starting the medication or increasing the dose. For many patients, they improve within the first few weeks.

However, not everyone tolerates these medications well. In some cases, side effects may lead patients to discontinue treatment. Rare but serious risks, such as pancreatitis, have also been reported, though they are uncommon.

More Than Blood Sugar Control

One of the most exciting aspects of GLP-1 medications is that their benefits may extend beyond glucose control.

Research has shown potential for:

• Reduced risk of heart attack and stroke

• Improved cardiovascular outcomes

• Possible anti-inflammatory effects

There is even early research exploring potential neurological benefits, though more studies are needed to fully understand these effects.

A Word on Weight Loss

While weight loss is a major advantage of these medications, it’s important to approach it thoughtfully. Patients who rely solely on medication without making sustainable lifestyle changes, like improving diet and incorporating regular exercise, may find that the weight returns after stopping the medication.

Additionally, weight loss can include not just fat, but also muscle mass. Since muscle plays a key role in metabolism, losing it can make long-term weight management more challenging.

Choosing the Right Patient

GLP-1 medications are powerful tools—but they are not a one-size-fits-all solution.

The key to success lies in:

• Careful patient selection

• Ongoing monitoring

• Combining medication with healthy lifestyle changes

When used appropriately, these medications can be transformative, not just for blood sugar control, but for overall health. We’re in an exciting time in diabetes care. Compared to just a decade ago, we now have more effective and safer treatment options—many of which not only manage blood sugar but also improve long-term health outcomes.

GLP-1 medications are at the forefront of that shift. And while they may not be right for everyone, they represent a significant step forward in how we care for patients with diabetes.